The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
1 tablet contains linezolid, in terms of 100%, 600 mg.
Treatment of infections caused by susceptible strains of aerobic and anaerobic gram-positive bacteria, including infections, accompanied by bacteremia, such as: nosocomial pneumonia; community acquired pneumonia; complicated infections of the skin and its structures, particularly infections secondary to the diabetic foot without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-sensitive and methicillin-resistant isolates), Streptococcus pyogenes, or Streptococcus agalactiae; uncomplicated infections of the skin and its structures caused by Staphylococcus aureus (methicillin-sensitive isolates only) or Streptococcus pyogenes; infections caused by enterococci, including vancomycin-resistant strains of Enterococcus faecium and faecalis. If infection pathogens include gram-negative bacteria, combination therapy is clinically indicated.
If you have information about any adverse effects or other drug-related problems, please fill in the form